Dietary fish oil suppresses experimental immunoglobulin a nephropathy in mice

Journal of Nutrition

Volumn 132, Issue 2, 2002, Pages 261-269

  Pestka, James J ^a   Zhou, Hui Ren ^a   Jia, Qunshan ^a   Timmer, Ann M ^a  

^a Michigan State University   (United States)

Author keywords

(n 3) polyunsaturated fatty acids; Fish oil; IgA nephropathy; Kidney; Mice; Trichothecene; Vomitoxin

Indexed keywords

ANTIOXIDANT; CORN OIL; FISH OIL; IMMUNOGLOBULIN A; MYCOTOXIN; POLYUNSATURATED FATTY ACID; TERT BUTYLHYDROQUINONE; TRICHOTHECENE; VOMITOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; KIDNEY DISEASE; MALE; MOUSE; NONHUMAN; SPLEEN CELL;

ANIMALIA; ZEA MAYS;

EID: 0036170775     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.2.261     Document Type: Article

References (75)

1. n-3 polyunsaturated fatty acids and immune function
2. The importance of omega-3 fatty acids in the attenuation of immune-mediated diseases
3. Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids
4. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
5. Fish oil fatty acids and experimental arthritis
6. Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains
7. Suppression of autoimmune disease by dietary n-3 fatty acids
8. Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats
9. Essential fatty acids and rheumatoid arthritis
10. Lipid mediators, free fatty acids and psoriasis
11. Esential fatty acids in atopic eczema: Clinical studies
12. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus
13. The commonest glomerulonephritis in the world: IgA nephropathy
14. A controlled trial of fish oil in IgA nephropathy
15. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA
16. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial
17. IgA nephropathy
18. IgA nephropathy: Pathogenesis of the most common form of glomerulonephritis
19. Etiology of IgA nephropathy syndrome
20. ACE gene polymorphism and IgA nephropathy: An ethnically homogeneous study and a meta-analysis
21. Dietary gluten and primary IgA nephropathy
22. The pathogenetic potential of environmental antigens in IgA nephropathy
23. Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol
24. Treatment of IgA nephropathy
25. Omega-3 polyunsaturated fatty acids: A potential new treatment of immune renal disease
26. Essential fatty acid deficiency profiles in idiopathic immunoglobulin A nephropathy
27. Risk factors for IgA nephropathy: A case-control study in Japan
28. Eicosapentaenoic acid and IgA nephropathy
29. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy
30. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial
31. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: A prospective, double-blind, randomized study
32. The relevance of experimental models in the pathogenetic investigation of primary IgA nephropathy
33. Dysregulation of IgA production and IgA nephropathy induced by the trichothecene vomitoxin
34. Quantitative assessment of mesangial immunoglobulin A (IgA) accumulation, elevated circulating IgA immune complexes, and hematuria during vomitoxin-induced IgA nephropathy
35. Persistent dysregulation of IgA production and IgA nephropathy in the B6C3F1 mouse following withdrawal of dietary vomitoxin (deoxynivalenol)
36. Elevated membrane IgA+ and CD4+ (T helper) populations in murine Peyer's patch and splenic lymphocytes during dietary administration of the trichothecene vomitoxin (deoxynivalenol)
37. Effect of dietary administration of the trichothecene vomitoxin (deoxynivalenol) on IgA and IgG secretion by Peyer's patch and splenic lymphocytes
38. Dietary exposure to the trichothecene vomitoxin (deoxynivalenol) stimulates terminal differentiation of Peyer's patch B cells to IgA secreting plasma cells
39. Immunomodulation by fungal toxins
40. Purification of deoxynivalenol (vomitoxin) by water-saturated silica gel chromatography
41. Structure-function relationships of 12,13-epoxytrichothecene mycotoxins in cell culture: Comparison to whole animal lethality
42. Second report of the ad hoc committee on standards for nutritional studies
43. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet
44. Composition of IgA immune complexes precipitation with polyethylene glycol. A model for isolation and analysis of immune complexes
45. Interpretation of immunofluorescent patterns in renal diseases
46. Toxicology of deoxynivalenol (vomitoxin)
47. Role of gender and strain in vomitoxin-induced dysregulation of IgA production and IgA nephropathy in the mouse
48. Polyclonal autoreactive IgA increase and mesangial deposition during vomitoxin-induced IgA nephropahty in the BALB/c mouse
49. Low levels of eicosapentaenoic and docosahexaenoic acids mimic the effects of fish oil upon rat lymphocytes
50. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity
51. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice
52. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages
53. Vomitoxin (deoxynivalenol)-induced IgA nephropathy in the B6C3F1 mouse: Dose response and male predilection
54. Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E
55. Vitamin E ameliorates renal injury in an experimental model of immunoglobulin A nephropathy
56. Effects of fish oil and alpha-tocopherol in immunoglobulin A nephropathy in the rat
57. Familial IgA nephropathy
58. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella
59. The role of interleukin-6 in mucosal IgA antibody responses in vivo
60. Quantitative analysis of interleukin 6 (IL-6) in patients with IgA nephropathy after tonsillectomy
61. Urinary IL-6/EGF ratio: A useful prognostic marker for the progression of renal damage in IgA nephropathy
62. Increased interleukin 6 mRNA expression by peripheral blood T cells from patients with IgA nephropathy
63. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin
64. Role of macrophages in elevated IgA and IL-6 production by Peyer's patch cultures following acute oral vomitoxin exposure
65. Polyspecific and autoreactive IgA secreted by hybridomas derived from Peyer's patches of vomitoxin-fed mice: Characterization and possible pathogenic role in IgA nephropathy
66. IgA polyspecific autoantibodies in IgA nephropathy
67. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells
68. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol)
69. Superinduction of TNF-alpha and IL-6 in macrophages by vomitoxin (deoxynivalenol) modulated by mRNA stabilization
70. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): Dose response and time course
71. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin
72. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion
73. Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis
74. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women